These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20567945)

  • 1. An update on the neurologic applications of botulinum toxins.
    Evidente VG; Adler CH
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic uses of botulinum toxin.
    Wheeler AH
    Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin: clinical use.
    Truong DD; Jost WH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin in neurology].
    Vidailhet M
    Rev Med Interne; 2005 Jul; 26(7):531-3. PubMed ID: 15975692
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Movement disorders and botulinum toxin in neurology].
    Sangla S; Trocello JM; Bourdain F; Vidal JS; Gallouedec G; Vidailhet M
    Ann Readapt Med Phys; 2003 Jul; 46(6):307-11. PubMed ID: 12928135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for the treatment of movement disorders.
    Thenganatt MA; Fahn S
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):399-409. PubMed ID: 22661378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on new and unique uses of botulinum toxin in movement disorders.
    Jankovic J
    Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic indications for botulinum toxins.
    Cordivari C; Misra VP; Catania S; Lees AJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case studies in movement disorders.
    Evidente VG; Caviness JN; Adler CH
    Semin Neurol; 2003 Sep; 23(3):277-84. PubMed ID: 14722823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin: State of the art.
    Jankovic J
    Mov Disord; 2017 Aug; 32(8):1131-1138. PubMed ID: 28639368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms.
    Wan XH; Vuong KD; Jankovic J
    Chin Med Sci J; 2005 Mar; 20(1):44-7. PubMed ID: 15844312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Neurotoxin Type A in Neurology: Update.
    Orsini M; Leite MA; Chung TM; Bocca W; de Souza JA; de Souza OG; Moreira RP; Bastos VH; Teixeira S; Oliveira AB; Moraes Bda S; Matta AP; Jacinto LJ
    Neurol Int; 2015 Sep; 7(2):5886. PubMed ID: 26487928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.